Federal Minister of Health tables the 2024 Annual Report of the Patented Medicine Prices Review Board
Safety Classified by Officially
Sales of patented medicines in Canada were $22.1 billion in 2024, a 10.9% increase over the year before.
December 3, 2025 — Ottawa, ON — Patented Medicine Prices Review Board
The Honourable Marjorie Michel, Federal Minister of Health, today tabled the 2024 Annual Report of the Patented Medicine Prices Review Board (PMPRB) with the Clerks of the Senate and the House of Commons.
The 2024 Annual Report reviews trends in the prices and sales of patented medicines in Canada. Sales of patented medicines in 2024 were $22.1 billion and accounted for approximately 47% of the sales of all medicines in Canada.
The report also sets out findings on spending on pharmaceutical research and development in Canada, as well as updated information on the PMPRB’s price review and reporting activities in 2024.
The PMPRB is an independent quasi-judicial body that protects the interests of Canadian consumers by ensuring the prices of patented medicines sold in Canada are not excessive. The PMPRB also reports on pharmaceutical price, cost, and utilization information to support timely and knowledgeable pricing, purchasing, and reimbursement decisions.
1,137 patented medicines for human use were reported to the PMPRB in 2024, including 53 new medicines.
Canadian list prices for patented medicines were higher on average than all PMPRB11 countries in 2024 and fifth highest among the 31 Organisation for Economic Co-operation and Development (OECD) countries.
Since 1987, costs for patented and generic medicines in Canada have grown at an average annual rate of 6.7%, close to three times the rate of inflation. Pharmaceutical spending makes up 13.7% of total health care spending.
This is an extract. The publication continues at the source.
Source: Patented Medicine Prices Review Board. Licence
Read the original at the source: https://www.canada.ca/en/patented-medicine-prices-review/news/2025/12/federal-minister-of-health-tables-the-2024-annual-report-of-the-patented-medicine-prices-review-board.html
Officially imported this from Patented Medicine Prices Review Board’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Patented Medicine Prices Review Board — imported from official source
- Official source
- https://api.io.canada.ca/io-server/gc/news/en/v2?dept=patentedmedicinepricesreviewboard&sort=publishedDate&orderBy=desc&publishedDate%3E=2021-07-23&pick=50&format=atom&atomtitle=Patented%20Medicine%20Prices%20Review%20Board ATOM
- Imported
- October 03, 2026 20:43
- Versions
- 1 recorded
- Identity
-
https://www.canada.ca/en/patented-medicine-prices-review/news/2025/12/federal-minister-...